Clinical Trial Update: CBT as an Adjunct to SRIs in the Treatment of BDD [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating cognitive-behavioral therapy as an adjunct to selective serotonin reuptake inhibitors for body dysmorphic disorder was terminated. Resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Body Dysmorphic Disorder

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Body Dysmorphic Disorder | Phase 4 | Status: TERMINATED | Results posted: 2017-03-09